Suchergebnisse - "D'Avanzo, Francesca"

PubPharm (57)

1

Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer : Results of a propensity-matched analysis of the OnCovid registry

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2024

von Mostaghim, A. | Minkove, S. | Aguilar-Company, J. | +43

2

A novel CRISPR/Cas9-based iduronate-2-sulfatase (IDS) knockout human neuronal cell line reveals earliest pathological changes

enthalten in: Scientific reports | 2023

von Badenetti, L. | Manzoli, R. | Trevisan, M. | +3

3

Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Tagliamento, M. | Gennari, A. | Lambertini, M. | +50

4

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer : results from the OnCovid registry

enthalten in: The Lancet. Oncology | 2023

von Cortellini, A. | Tabernero, J. | Mukherjee, U. | +126

5

Mucopolysaccharidoses Differential Diagnosis by Mass Spectrometry-Based Analysis of Urine Free Glycosaminoglycans-A Diagnostic Prediction Model

enthalten in: Biomolecules | 2023

von D'Avanzo, F. | Zanetti, A. | Dardis, A. | +4

6

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Pinato, D. | Ferrante, D. | Aguilar-Company, J. | +149

7

Generation of an induced pluripotent stem cells line, CSSi014-A 9407, carrying the variant c.479C>T in the human iduronate 2-sulfatase (hIDS) gene

enthalten in: Stem cell research | 2022

von Casamassa, A. | Zanetti, A. | Ferrari, D. | +9

8

Glycosaminoglycan signatures in body fluids of mucopolysaccharidosis type II mouse model under long-term enzyme replacement therapy

enthalten in: Journal of molecular medicine (Berlin, Germany) | 2022

von Maccari, F. | Rigon, L. | Mantovani, V. | +8

9

Glycosaminoglycan signatures in body fluids of mucopolysaccharidosis type II mouse model under long-term enzyme replacement therapy

enthalten in: Journal of molecular medicine | 2022

von Maccari, F. | Rigon, L. | Mantovani, V. | +8

10

Glycosaminoglycan signatures in body fluids of mucopolysaccharidosis type II mouse model under long-term enzyme replacement therapy

enthalten in: Journal of molecular medicine | 2022

von Maccari, F. | Rigon, L. | Mantovani, V. | +8

1
2
3
4
5
6
Nächster »
[6]